JO
EVLO

John Overdeck’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

John Overdeck’s Portfolio EVLO Stock Details EVLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,306
Closed -$55K – 2958
2022
Q2 		$55K Sell
1,306
-3,890
-75% -$180K ﹤0.01% 2335
2022
Q1 		$352K Buy
5,196
+4,529
+679% +$377K ﹤0.01% 2161
2021
Q4 		$81K Sell
667
-168
-20% -$28.4K ﹤0.01% 4097
2021
Q3 		$118K Sell
835
-3,340
-80% -$662K ﹤0.01% 4064
2021
Q2 		$1.15M Sell
4,175
-2,710
-39% -$684K ﹤0.01% 2354
2021
Q1 		$1.47M Buy
+6,885
New +$1.9M ﹤0.01% 1957

Other funds holding EVLO

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $170M AUM 34.45% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

John Overdeck's EVLO Position: Q3 2022 in Review

John Overdeck sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q3 2022, closing a stake of 1,306 shares — an estimated $55K sold.

John Overdeck first reported a position in EVLO in Q1 2021 and held it in 6 quarters. The position peaked at $1.47M in Q1 2021. 41 funds tracked by Wall St. Rank hold EVLO as of Q3 2022.

  • John Overdeck reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • John Overdeck sold 1,306 Evelo Biosciences, Inc. Common Stock shares in Q3 2022, an estimated $55K.
  • John Overdeck first reported a position in Evelo Biosciences, Inc. Common Stock in Q1 2021 and held it in 6 quarters.
  • John Overdeck's Evelo Biosciences, Inc. Common Stock position peaked at $1.47M in Q1 2021.
  • 41 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q3 2022.

Based on Two Sigma Investments's 13F filing for Q3 2022, filed 14 Nov 2022.